Here are five insights:
1. He sold the shares at an average share price of $74.22, totaling about $1.84 million.
2. The company submitted a legal filing with the Securities & Exchange Commission detailing the transaction.
3. NuVasive has a 50-day moving average of $72.90 and a 200-day moving average of $67.27.
4. With a 52-week low of $44.02, NuVasive has a 52-week high of $76.28.
5. The company has a market capitalization of $3.79 billion.
More articles on devices:
Stryker, K2M, SI-Bone & more: 17 device company key notes
Germany dominates European total ankle replacement market — 6 points
Global cervical total disc replacement device market to see growth in ASC sector: 7 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
